Publications by authors named "Tetsu Hayashida"

Claim this Profile
A
A retrospective multi-center cohort study investigating safety of sentinel lymph node biopsy for axillary staging in clinical T3-4c breast cancer.
Sayaka Kuba, Yasuaki Sagara, Hiroshi Yano, Shigeto Maeda, Takehiko Sakai, Tetsu Hayashida

Breast Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Breast Cancer Risk Management in HBOC Patients: Image Surveillance Versus Risk-reducing Surgery.
Tomoko Seki, Yusuke Kobayashi, Kenta Masuda, Kohei Nakamura, Mamiko Yamada, Tetsu Hayashida

Keio J Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational study.
Shigeru Imoto, Hiroyuki Yasojima, Takeshi Nagashima, Tatsuya Onishi, Tsutomu Takashima, Tetsu Hayashida

Breast Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer.
Yuko Kawai, Aiko Nagayama, Kazuhiro Miyao, Makoto Takeuchi, Takamichi Yokoe, Tetsu Hayashida

Breast Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Future of Breast Cancer Diagnosis in Japan with AI and Ultrasonography.
Tomoyuki Fujioka, Jitsuro Tsukada, Tetsu Hayashida, Emi Yamaga, Hiroko Tsukada

JMA J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis on the effect of body tissues and surgical tools on workflow recognition in first person surgical videos.
Hisako Tomita, Naoto Ienaga, Hiroki Kajita, Tetsu Hayashida, Maki Sugimoto

Int J Comput Assist Radiol Surg· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC).
Ikuko Hirai, Keiji Tanese, Yoshio Nakamura, Keitaro Fukuda, Takeshi Ouchi, Tetsu Hayashida

Oncologist· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer.
Kaori Takahashi, Ryuji Uozumi, Toru Mukohara, Tetsu Hayashida, Midori Iwabe

Oncologist· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, Taku Yamashita, Koji Araki, Tetsu Hayashida

Int J Clin Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer.
Takehiro Yamamoto, Tetsu Hayashida, Yohei Masugi, Kiyotaka Oshikawa, Noriyo Hayakawa

Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Masayuki Nagahashi, YiWei Ling, Chie Toshikawa, Tetsu Hayashida, Yuko Kitagawa

Breast Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solitary fibrous tumor of the breast: A case report.
Chikako Hirose, Tetsu Hayashida, Junichi Saito, Akiharu Kubo, Shuji Mikami

Int J Surg Case Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer.
Akihiko Shimomura, Masayuki Yoshida, Takashi Kubo, Satoshi Yamashita, Emi Noguchi, Tetsu Hayashida

Breast Cancer Res Treat· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorodeoxyglucose-positron emission tomography as a potential alternative tool for functional diagnosis of glycogen storage disease type I.
Takeshi Sato, Mikako Inokuchi, Satsuki Nakano, Yu Iwabuchi, Tetsu Hayashida

Radiol Case Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polysulfide Serves as a Hallmark of Desmoplastic Reaction to Differentially Diagnose Ductal Carcinoma In Situ and Invasive Breast Cancer by SERS Imaging.
Akiko Kubo, Yohei Masugi, Takeshi Hase, Kengo Nagashima, Yuko Kawai, Tetsu Hayashida

Antioxidants (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical application.
Tetsu Hayashida, Erina Odani, Masayuki Kikuchi, Aiko Nagayama, Tomoko Seki

Cancer Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between a new assay system, Elecsys Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study.
Takashi Suzuki, Yoko Oshima, Fumiaki Shiratori, Tatsuki Nanami, Satoshi Yajima, Tetsu Hayashida

Mol Clin Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility study on collecting patient-reported outcomes from breast cancer patients using the LINE-ePRO system.
Tetsu Hayashida, Aiko Nagayama, Tomoko Seki, Maiko Takahashi, Akiko Matsumoto

Cancer Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between work-related outcomes and symptoms in early breast cancer survivors receiving adjuvant endocrine therapy.
Mayumi Nakao, Hiroko Komatsu, Tetsu Hayashida, Maiko Takahashi, Tomoko Seki

Asia Pac J Oncol Nurs· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA.
Kuniko Sunami, Hideaki Bando, Yasushi Yatabe, Yoichi Naito, Hideaki Takahashi, Tetsu Hayashida

Cancer Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin.
Xiaozhong Teng, Tetsu Hayashida, Takeshi Murata, Aiko Nagayama, Tomoko Seki

Breast Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development.
Ayako Nakashoji, Tetsu Hayashida, Shigeo Yamaguchi, Yuko Kawai, Masayuki Kikuchi

Breast Cancer Res Treat· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
Hinako Maeda, Tetsu Hayashida, Rurina Watanuki, Masayuki Kikuchi, Ayako Nakashoji

Breast Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status.
Kohei Nakamura, Eriko Aimono, Junna Oba, Hideyuki Hayashi, Shigeki Tanishima, Tetsu Hayashida

Med Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1).
Yoichi Naito, Hiroyuki Aburatani, Toraji Amano, Eishi Baba, Toru Furukawa, Tetsu Hayashida

Int J Clin Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis